SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-152366
Filing Date
2020-05-27
Accepted
2020-05-27 08:42:03
Documents
7
Period of Report
2020-05-26
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d925005d8k.htm 8-K 78833
2 EX-3.1 d925005dex31.htm EX-3.1 8932
3 EX-3.2 d925005dex32.htm EX-3.2 7571
4 EX-3.3 d925005dex33.htm EX-3.3 157498
5 EX-10.1 d925005dex101.htm EX-10.1 150820
6 EX-99.1 d925005dex991.htm EX-99.1 12725
7 GRAPHIC g925005g0527020301311.jpg GRAPHIC 3389
  Complete submission text file 0001193125-20-152366.txt   422948
Mailing Address 16745 WEST BERNARDO DRIVE SUITE 250 San Diego CA 92127
Business Address 16745 WEST BERNARDO DRIVE SUITE 250 San Diego CA 92127 (858) 376-2600
Histogen Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36003 | Film No.: 20912837
SIC: 2834 Pharmaceutical Preparations